Join us for a special episode covering Blue Innovation Day 2024, a showcase of ocean sustainability technologies and activities in Santa Cruz. Learn about the latest in clean energy solutions, a new study on predicting cardiovascular disease risk using the body roundness index, and explore the unseen world of electricity with author Gerald E. Ulen.
Today's episode explores the innovative approaches of companies like OS Therapies Inc., Actinium Pharmaceuticals, Corbus Pharmaceuticals, and Puma Biotechnology in reshaping cancer treatment. These companies are developing cutting-edge therapies for various types of cancer, showing promising results and strong financial standings in the biotech sector. Additionally, a new scientific statement from the American Heart Association emphasizes the importance of a coordinated healthcare team for children with Trisomy 21 and congenital heart disease, highlighting the need for improved care coordination and support for these individuals.
Today's episode discusses the importance of maintaining good cardiovascular health during the first trimester of pregnancy to potentially offset the genetic risk of developing preeclampsia and gestational hypertension. Research presented at the American Heart Association’s Hypertension Scientific Sessions 2024 shows that focusing on cardiovascular health improvement, nutrition, weight management, and healthy blood pressure early in pregnancy can lower the risk of adverse outcomes. In other news, the 18th Annual Pain Therapeutics Summit in Boston will feature cutting-edge research, innovative treatment strategies, and discussions on the evolving role of patients in clinical research.
Today's episode covers a range of topics from the American Heart Association's Hypertension Scientific Sessions 2024, including the importance of proper cuff sizes for accurate blood pressure monitoring, the effectiveness of bariatric surgery in managing high blood pressure, a program combining remote monitoring and pharmacist interactions to lower blood pressure, concerning trends in high blood pressure among young adults and children, and the groundbreaking potential of Telomir-1 in longevity science. Additionally, official reports on multiple UFO sightings in Brazilian airspace suggest a new chapter in history.
The PAD Collaborative launches an interactive heat map to highlight the risk of lower limb amputations from PAD, emphasizing the need for improved healthcare services and prevention efforts. Brad Morrison from the Texas Space Commission shares Texas' ambitious plans to become a hub for space innovation, focusing on partnerships and initiatives to drive economic growth in the industry.
Today's episode covers groundbreaking research on improving daily streamflow forecasts in data-scarce transboundary basins like the Dulong-Irrawaddy River Basin. The innovative transfer learning model developed by researchers from Yunnan University and Pennsylvania State University sets a new standard for water resource forecasting, offering transformative solutions for water security in vulnerable areas. This study marks a significant advancement in hydrological science, emphasizing the importance of accurate streamflow predictions in enhancing water resource management.
Join us as we explore the future of autonomous aviation with CEO Brandon Robinson of Horizon Aircraft and their groundbreaking Cavorite X7 eVTOL aircraft. Discover how advanced sensors and fly-by-wire systems are paving the way for a future where autonomous air travel could become the norm, offering benefits like bypassing ground traffic and improving safety and efficiency. With promising technical updates and progress on the horizon, Horizon Aircraft is confident in making its vision a reality.
Rogue Space Systems Corporation has been awarded over 1 million dollars for their groundbreaking satellite-characterization upgrades with the Contactless LAser Satellite Stethoscope (CLASS) project. This technology aims to improve space traffic management by identifying and diagnosing Resident-Space-Objects using a laser vibrometer. The success story highlights the impact of SBIR and STTR initiatives on small businesses, as Rogue's CEO and COO discuss the importance of this technology for their fleet of Orbots™ and in-space logistics services.
Join us in this episode as we dive into Panther Minerals Inc.'s strategic growth plans in the booming uranium market. With a focus on high-quality projects like Boulder Creek and Fireweed prospects, the company is utilizing advanced technology to identify key exploration areas. Learn about their recent acquisitions and successful fundraising efforts to support their expansion goals.
Join us as we discuss Alzamend Neuro, Inc.'s partnership with Massachusetts General Hospital for a Phase II trial of a next-generation treatment for Major Depressive Disorder (MDD). Learn about the innovative approach of using AL001, a lithium-based therapeutic candidate, to address the symptoms of MDD. CEO Stephan Jackman shares his optimism for the potential of AL001 as a safer and more effective alternative for MDD treatment. Alzamend Neuro is also actively involved in Phase II trials for bipolar disorder and Alzheimer's disease, with Dr. Ovidiu Andronesi leading the way.
Join us as we explore Li-FT Power's focus on lithium exploration in Canada with CEO Francis MacDonald. Learn about the high concentrations of lithium found in the Yellowknife Lithium Project and the potential for discovery in Quebec. Discover how the Cali Project in the Northwest Territories positions Li-FT for growth in the near future.
In this episode, we discuss Alzamend Neuro, Inc.'s partnership with Massachusetts General Hospital for a Phase II clinical trial of AL001, a potential game-changer for bipolar disorder treatment. The study aims to establish AL001's safe, effective, and tolerable dosing requirements, potentially simplifying treatment regimens and improving patient compliance. We also explore the rising impact of mental health issues globally and how Alzamend Neuro is advancing new treatments for various conditions. Additionally, we cover BioLumic's innovative use of light to enhance inbred corn lines, with promising results and plans for commercialization in 2025.
Join us as we explore Theriva Biologics' innovative approach to oncolytic virus therapies, aimed at improving survival rates for difficult-to-treat cancers like brain tumors and pancreatic cancers. Learn about their leading candidate, VCN-01, and the promising results seen in clinical trials for various types of cancer. Discover how Theriva is pushing the boundaries with next-generation viruses like VCN-11 with Albumin Shield technology, paving the way for future advancements in cancer treatment.
In this episode, we discuss the rising prevalence of pancreatic cancer and the promising treatment being developed by Oncolytics Biotech Inc. called pelareorep. The GOBLET study is currently testing pelareorep in combination with mFOLFIRINOX and atezolizumab in newly diagnosed metastatic pancreatic cancer patients, with positive results in previous trials and Fast Track Designation from the FDA. This innovative therapy could offer new hope for pancreatic cancer patients and improve outcomes.
Today's episode covers the latest advancements in mental health treatment by MIRA Pharmaceuticals (NASDAQ: MIRA), with promising preclinical trial results for compounds MIRA-55 and Ketamir-2. MIRA-55 offers therapeutic benefits without side effects like increased appetite or paranoia, while Ketamir-2 targets treatment-resistant depression. With a focus on patient care, MIRA aims to improve access and affordability, potentially changing the standard of care for neurological and neuropsychiatric disorders. In other news, Doubleview Gold Corp has resumed drilling at the Hat Project in Northern British Columbia, utilizing technical and statistical models to improve grade and explore mineralization trends for a future Mineral Resource Estimate.
Golden Shield Resources has acquired Tucano Gold, gaining exposure to exploration opportunities at Marudi and a high-grade gold asset in Brazil. The acquisition includes Mina Tucano, an open-pit operation with underground potential, set to restart production in Q4 2024. Classiq has launched Qmod, a high-level language for quantum coding, making quantum computing more accessible. CEO Nir Minerbi believes Qmod will simplify complex problems with its declarative nature and industry readiness.
Today's episode covers various updates in the mining and exploration industry, including North Bay Resources Inc.'s acquisition of the Mt Vernon Mine, Fathom Nickel Inc's exploration update on the Gochager Lake property, Northstar Gold Corp.'s successful private placement, Standard Uranium Ltd's prospecting results at the Sun Dog Uranium Project, and Endurance Gold's drilling campaign at the Reliance Gold Property. Additionally, the episode highlights a groundbreaking clinical study on Depression in Cancer Patients by ABVC BioPharma Inc. and AiBtl BioPharma Inc., as well as K2 Laboratory's milestone achievement in obtaining NDC codes for their research projects. The episode concludes with the launch of Briefly Bio, a techbio startup revolutionizing experiment documentation in biology.
Today's episode covers the rising investor interest in mining stocks, particularly gold mining companies, as gold prices soar and mining costs stabilize. Anticipation of a Federal Reserve rate cut could further boost these stocks, making it an opportune time to consider investing. First Nordic Metals Corp. shines in the junior mining sector with its Barsele gold project in Sweden, boasting a substantial gold resource and ongoing exploration activities. Additionally, new scientific studies highlight the alarming decline of giant sequoia seedlings in areas affected by recent mega-fires, emphasizing the need for restoration efforts. Lastly, Intrepid Metals Corp CEO shares promising results from the initial drill program at the Corral Copper Property in Arizona, showing high-grade intercepts and potential for further exploration.
Rogue Space Systems Corporation secures a Phase II SBIR to enhance Space Domain Awareness with SAMRIC technology. Pegasus Resources acquires the Jupiter Project in Utah, while Condor Resources provides updates on various projects in Peru. Gold Basin Resources shares positive assay results from the Gold Basin oxide gold project in Arizona. Millennial Potash secures a 70 percent interest in the Banio Potash Project with a promising Preliminary Economic Assessment. Cure Alzheimer’s Fund achieves record-breaking fundraising results in 2023. Pulsar Helium Inc. CEO discusses the company's progress and future plans in the helium sector.
Today's episode features discussions with CEOs from CVW CleanTech, Group Eleven Resources Corp, Torr Metals, American Eagle Gold, and Volta Metals. CVW CleanTech's innovative technology reduces methane emissions from oil sands mining, while Group Eleven Resources Corp is optimistic about zinc discoveries in Ireland. Torr Metals receives a three-year exploration permit for its Filion gold project, and American Eagle Gold announces a significant copper discovery in British Columbia. Volta Metals expands its lithium project portfolio in northwestern Ontario with strategic acquisitions.